Acromegaly or pituitary gigantism (Q39840): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Acromegalia é um distúrbio adquirido relacionado à produção excessiva de hormônio do crescimento (GH) e caracterizado por desfiguração somática progressiva (envolvendo principalmente a face e extremidades) e manifestações sistêmicas. As principais características clínicas são extremidades alargadas (mãos e pés), dedos grossos, alargados e atarracados e tecido mole espessado. A doença também tem consequências reumatológicas, cardiovasculares, respiratórias e metabólicas que determinam o seu prognóstico. Na maioria dos casos, a acromegalia está relacionada a um adenoma hipofisário, puramente secretor de GH (60%) ou misto. A cirurgia transesfenoidal costuma ser o tratamento de primeira linha. Quando a cirurgia não corrige a hipersecreção de GH/IGF-I, o tratamento com análogos da somatostatina e/ou radioterapia pode ser usado.
description / endescription / en
 
Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterised by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The main clinical features are broadened extremities (hands and feet), widened thickened and stubby fingers, and thickened soft tissue. The disease also has rheumatologic, cardiovascular, respiratory and metabolic consequences which determine its prognosis. In the majority of cases, acromegaly is related to a pituitary adenoma, either purely GH-secreting (60%) or mixed. Transsphenoidal surgery is often the first-line treatment. When surgery fails to correct GH/IGF-I hypersecretion, medical treatment with somatostatin analogs and/or radiotherapy can be used.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/825410563 / rank
 
Normal rank
Property / CURIE
 
CID11:5A60.0
Property / CURIE: CID11:5A60.0 / rank
 
Normal rank
Property / Canary Token
 
dki-india-5A60.0
Property / Canary Token: dki-india-5A60.0 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: E22.0 / rank
 
Normal rank

Latest revision as of 05:23, 13 August 2026

Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterised by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The main clinical features are broadened extremities (hands and feet), widened thickened and stubby fingers, and thickened soft tissue. The disease also has rheumatologic, cardiovascular, respiratory and metabolic consequences which determine its prognosis. In the majority of cases, acromegaly is related to a pituitary adenoma, either purely GH-secreting (60%) or mixed. Transsphenoidal surgery is often the first-line treatment. When surgery fails to correct GH/IGF-I hypersecretion, medical treatment with somatostatin analogs and/or radiotherapy can be used.
Language Label Description Also known as
default for all languages
5A60.0
    English
    Acromegaly or pituitary gigantism
    Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterised by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The main clinical features are broadened extremities (hands and feet), widened thickened and stubby fingers, and thickened soft tissue. The disease also has rheumatologic, cardiovascular, respiratory and metabolic consequences which determine its prognosis. In the majority of cases, acromegaly is related to a pituitary adenoma, either purely GH-secreting (60%) or mixed. Transsphenoidal surgery is often the first-line treatment. When surgery fails to correct GH/IGF-I hypersecretion, medical treatment with somatostatin analogs and/or radiotherapy can be used.

      Statements

      CID11:5A60.0
      0 references
      dki-india-5A60.0
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references